The Political Economy of Global Vaccine Nationalism
Towards Building Agency for Africa’s Drug Manufacturing Capacity
Bibliographic Data
| ID | 12976238 |
|---|---|
| Authors | Mzukisi Qobo (0000-0002-7778-3811, University of the Witwatersrand, corresponding author), Mills Soko (University of the Witwatersrand), Matlala Setlhalogile (University of the Witwatersrand) |
| Year | 2021 |
| Volume | 15 |
| Issue | 1 |
| Pages | 4-25 |
| Publication date | 2021-12-06 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | African Security (JOURNAL) |
| Journal identifiers | ISSN: 1939-2206 • E-ISSN: 1939-2214 |
| Publisher | Taylor & Francis (PUBLISHER • GB) |
| DOI | 10.1080/19392206.2021.2009099 |
| OpenAlex | W4200083889 |
| Language | EN |
| Citations received | 1 |
Since the World Health Organization declared Covid-19 a global pandemic in early 2020, several countries have moved from non-pharmaceutical interventions in combatting the Covid-19 pandemic to developing vaccine acquisition strategies. Many developed countries adopted strategies to secure and stockpile vaccines. Pharmaceutical firms used their bargaining power to negotiate steep vaccine prices in developing nations. Vaccine nationalism and the predatory behavior of pharmaceutical firms make the case for temporarily lifting intellectual property protections a morally compelling one. African countries must work together to build vaccine manufacturing capacity through scientific cooperation, development of human capital, and nurturing of value chains
Agency (philosophy · Business · Coronavirus disease 2019 (COVID-19 · Developing country · Development economics · Economic growth · Economics · Infectious disease (medical specialty · Intellectual property · International trade · Nationalism · Negotiation · Pandemic · Pharmaceutical industry · Political science · Politics · Sociology · Work (physics · Economic Growth and Development · Innovation and Socioeconomic Development · Law · Medicine · Pharmaceutical Economics and Policy
| Unique citing works | 1 |
|---|---|
| Citations per year | 0,5 |
| Citation span | 2024 - 2024 (1) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 1 |